Loading…
Health In Tech, Inc. is projected to rise to $1.09 by 2027, a +2% move from its current price of $1.06. HIT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $1.02 | $1.06 | $1.10 | -0.02% |
| Jul 15 | $1.00 | $1.06 | $1.12 | -0.05% |
| Jul 16 | $0.9911 | $1.06 | $1.13 | -0.07% |
| Jul 17 | $0.9807 | $1.06 | $1.14 | -0.10% |
| Jul 18 | $0.9716 | $1.06 | $1.15 | -0.12% |
| Jul 19 | $0.9634 | $1.06 | $1.16 | -0.15% |
| Jul 20 | $0.956 | $1.06 | $1.17 | -0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.956 | $1.06 | $1.17 | -0.17% |
| Week 2 | $0.915 | $1.06 | $1.22 | -0.35% |
| Week 3 | $0.8844 | $1.05 | $1.26 | -0.52% |
| Week 4 | $0.8591 | $1.05 | $1.29 | -0.70% |
| Week 5 | $0.8373 | $1.05 | $1.32 | -0.87% |
| Week 6 | $0.8179 | $1.05 | $1.35 | -1.04% |
| Week 7 | $0.8004 | $1.05 | $1.37 | -1.22% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative functions on behalf of stop loss carriers; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers.
It also provides health intelligence (HI) cards to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.
Health In Tech, Inc. (HIT) is currently priced at $1.04 with a market cap of $68.16M and is ranked 4392. The asset sits in the Technology category and carries a mid-to-small cap profile given the market capitalization. The current price and market position align with a data-backed, growth-oriented outlook that shows a long-run upside potential.
A major floor 18.3% below — a decisive break under it would weaken the trend.
The nearest floor, 9.0% below — buyers have tended to step in here.
Price is pressing into resistance (2.8% away) — a breakout level to watch.
A major ceiling 91.5% above — clearing it would confirm fresh momentum.
Key HIT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HIT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.04 | Buy | $1.05 | Buy |
| MA 10 | $1.04 | Buy | $1.04 | Buy |
| MA 20 | $1.03 | Buy | $1.04 | Buy |
| MA 50 | $1.13 | Sell | $1.13 | Sell |
| MA 100 | $1.33 | Sell | $1.28 | Sell |
| MA 200 | $1.66 | Sell | $1.58 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.32 | Neutral |
| Stoch RSI (14) | 78.77 | Neutral |
| CCI (20) | 52.17 | Neutral |
| Williams %R (14) | -25.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 6.11 | Buy |
| Bollinger %B (20,2) | 0.68 | Neutral |
| Stochastic %K (14) | 75.00 | Neutral |
| TRIX (15) | -0.39 | Sell |
| Awesome (5,34) | 0.03 | Buy |
| Ultimate (7,14,28) | 55.07 | Neutral |
| Momentum (10) | 0.09 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 1.08 | Sell |
| ADX (14) | 12.30 | Neutral |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is Neutral. RSI(14) is 40, and the stock trades with a SMA50 of $1.23 and a SMA200 of $1.76. The current price of $1.04 sits above the stated support of $0.866 and below the resistance of $1.54. The 30-day range runs from a low of $0.7902 to a high of $1.37, placing the price in a mid-band range as volatility remains elevated.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.866 | $1.06 | $1.39 | 0% | Neutral | |
| $0.8322 | $1.09 | $1.52 | +2% | Neutral | |
| $0.7855 | $1.07 | $1.57 | +1% | Neutral | |
| $0.9685 | $1.36 | $2.08 | +29% | Bullish | |
| $1.15 | $1.67 | $2.62 | +57% | Bullish | |
| $1.14 | $1.70 | $2.75 | +60% | Bullish | |
| $1.13 | $1.73 | $2.87 | +63% | Bullish | |
| $1.02 | $1.61 | $2.72 | +52% | Bullish | |
| $1.09 | $1.75 | $3.03 | +66% | Bullish | |
| $1.35 | $2.22 | $3.92 | +110% | Bullish | |
| $1.44 | $2.65 | $5.05 | +150% | Bullish | |
| $2.48 | $5.50 | $11.70 | +419% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.866 | $1.06 | $1.29 | +0.00% |
| August 2026 | $0.9063 | $1.08 | $1.33 | +2.02% |
| September 2026 | $0.8597 | $1.04 | $1.30 | -4.18% |
| October 2026 | $0.845 | $1.03 | $1.30 | -0.86% |
| November 2026 | $0.8765 | $1.07 | $1.38 | +4.49% |
| December 2026 | $0.8679 | $1.07 | $1.39 | -0.31% |
Click any year to see its month-by-month HIT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, HIT is projected to trade between $0.866 and $1.39, averaging $1.06 — a potential gain of 0% from today's $1.06. Price action looks broadly range-bound.
Health In Tech, Inc.'s 2027 outlook centres on $1.09, within a $0.8322 to $1.52 range. That is up +2% on the projected 2026 average. That marks a +2% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, HIT could reach as high as $1.57, with a base case around $1.07 and support toward $0.7855 — roughly +1% from $1.06. Price action looks broadly range-bound.
Expect HIT to range from $0.9685 to $2.08 through 2029. The $1.36 average target implies a +29% move from current prices. That is up +28% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The HIT price prediction for 2030 points to an average of $1.67 (low $1.15, high $2.62) — a potential gain of +57% on today's $1.06. Momentum favours further upside here.
In 2031, HIT is projected to trade between $1.14 and $2.75, averaging $1.70 — a potential gain of +60% from today's $1.06. That is up +2% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Health In Tech, Inc.'s 2032 outlook centres on $1.73, within a $1.13 to $2.87 range. That is up +2% on the projected 2031 average. That marks a +63% change versus current levels. Momentum favours further upside here.
By 2033, HIT could reach as high as $2.72, with a base case around $1.61 and support toward $1.02 — roughly +52% from $1.06. Buyers look set to stay in control over this stretch.
Expect HIT to range from $1.09 to $3.03 through 2034. The $1.75 average target implies a +66% move from current prices. That is up +9% on the projected 2033 average. Momentum favours further upside here.
The HIT price prediction for 2035 points to an average of $2.22 (low $1.35, high $3.92) — a potential gain of +110% on today's $1.06. Buyers look set to stay in control over this stretch.
In 2040, HIT is projected to trade between $1.44 and $5.05, averaging $2.65 — a potential gain of +150% from today's $1.06. That is up +19% on the projected 2035 average. Momentum favours further upside here.
Health In Tech, Inc.'s 2050 outlook centres on $5.50, within a $2.48 to $11.70 range. That is up +107% on the projected 2040 average. That marks a +419% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in HIT today (≈ 943.396226 HIT) could be worth
$5,189.42
+$4,189.42 (+419%) by 2050 · US Dollar
Based on the average projected HIT price of $5.5 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HITwould be worth at today's price.
$1,000 invested in HIT on Jul 10, 2025 (≈ 900.900889 HIT) would be worth
$954.95
-$45.05 (-4.5%) today · 0.95× · US Dollar
Based on a HIT entry price of $1.11 vs. today's $1.06.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.01 | $1,049.5 | +5.0% |
| 1 month ago | $1.08 | $981.48 | -1.9% |
| 3 months ago | $1.34 | $791.04 | -20.9% |
| 6 months ago | $1.61 | $658.39 | -34.2% |
| 1 year ago | $1.11 | $954.95 | -4.5% |
| All time (1.5y) ago | $5.1 | $207.84 | -79.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HIT forecast.
Our base-case forecast reaches $2.10 around 2035.
Implied market cap at $2.10: $113.1M
The multi-year forecast shows a clear bullish tilt after 2028, with the 2029 average price at $1.41 and a max of $2.19 (ROI 35.4) and a bullish sentiment. By 2030 the average price is projected at $1.79 with a max of $2.88 and a 72.1 ROI, followed by continued upside through 2031 ($1.80 avg, $2.98 max, ROI 72.6) and 2032 ($1.77 avg, $3.01 max, ROI 69.8). The trajectory remains bullish through 2033 ($1.73 avg, $3.02 max, ROI 66.6) and 2034 ($1.90 avg, $3.38 max, ROI 82.8).
By 2035 the average price is $2.40 with a max of $4.35 and ROI of 130.3. The forecast accelerates further into 2040 (avg $2.92, max $5.75, ROI 181) and culminates in 2050 (avg $5.99, max $13.25, ROI 476.2). Overall, sentiment shifts to BULLISH in the later years, reflecting expected fundamental and price growth, though these are estimates and carry downside risk from volatility (annualized volatility 80).
Tap a question to reveal the answer.
In 2030 the forecast shows a min of $1.20, an avg of $1.79, and a max of $2.88, with a ROI of 72.1 and a BULLISH sentiment.
The forecast projects a long-run bullish trajectory with higher average prices and a ROI up to 476.2 by 2050, though early years show Neutral sentiment and returns that are not guaranteed.
Yes. The forecast for 2035 shows a max of $4.35 and an avg of $2.40, indicating a potential to exceed $4.00 within the forecast window.
The current price is $1.04 and the market cap is $68.16M.
RSI(14) is 40, SMA50 is $1.23, SMA200 is $1.76. The price is $1.04, with support at $0.866 and resistance at $1.54, and the 30-day range is $0.7902 to $1.37, with a NEUTRAL sentiment.
Health In Tech, Inc. Community Discussion
0Share your Health In Tech, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.